Western Blot: CD82/Kai-1 Antibody [NBP1-76775] - A549 cell lysate with CD82 antibody at (A) 0.5 and (B) 1 ug/ml.
Immunohistochemistry: CD82/Kai-1 Antibody - BSA Free [NBP1-76775] - Immunohistochemistry of CD82/Kai-1 in human colon tissue with CD82/Kai-1 antibody at 2.5 u/mL.
Immunocytochemistry/ Immunofluorescence: CD82/Kai-1 Antibody - BSA Free [NBP1-76775] - Immunofluorescence of CD82/Kai-1 in Human Colon cells with CD82/Kai-1 antibody at 20 u/mL.
Novus Biologicals Rabbit CD82/Kai-1 Antibody - BSA Free (NBP1-76775) is a polyclonal antibody validated for use in IHC, WB, ELISA, ICC/IF and IP. Anti-CD82/Kai-1 Antibody: Cited in 2 publications. All Novus Biologicals antibodies are covered by our 100% guarantee.
Immunogen
Antibody was raised against a 15 amino acid synthetic peptide from near the carboxy terminus of human KAI1. The immunogen is located within the last 50 amino acids of KAI1. Amino Acid Squence: CRHVHSEDYSKVPKY
Isotype
IgG
Clonality
Polyclonal
Host
Rabbit
Gene
CD82
Purity
Peptide affinity purified
Innovator's Reward
Test in a species/application not listed above to receive a full credit towards a future purchase.
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Buffer
PBS
Preservative
0.02% Sodium Azide
Concentration
1 mg/ml
Purity
Peptide affinity purified
Alternate Names for CD82/Kai-1 Antibody - BSA Free
CD82 antigenC33
CD82 molecule
CD82
IA4
IA4C33 antigen
Inducible membrane protein R2
KAI1
KAI1GR15
kangai 1 (suppression of tumorigenicity 6, prostate; CD82 antigen (R2 leukocyteantigen, antigen detected by monoclonal and IA4))
Metastasis suppressor Kangai-1
R2
SAR2
SAR2tetraspanin-27
ST6
ST6tspan-27
Suppressor of tumorigenicity 6 protein
Tetraspanin-27
TSPAN27
Tspan-27
TSPAN274F9
Background
KAI1 was initially identified from a T-cell activation study as a four-transmembrane protein that plays an accessory role in T-cell activation, and was later determined to act as a cancer metastasis suppressor gene. This protein is ubiquitously expressed at moderate to high levels in most tissues, but its expression is downregulated during tumor progression. The loss of KAI1 and p53 is associated with poor survival for prostate and other cancer patients. Recently, KAI1 was found to interact with DARC, the Duffy antigen for chemokines using a yeast two hybrid screen. It is thought that tumor cells dislodged from the primary tumor and expressing KAI1 interact with DARC proteins expressed on vascular cells, transmitting a senescent signal to the tumor cells, while tumor cells that have lost KAI1 expression can proliferate and potentially give rise to metastases. At least two isoforms of KAI1 are known to exist.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
=
÷
Review this Product
Be the first to review our CD82/Kai-1 Antibody - BSA Free and receive a gift card or discount.